Finance

Lists
MDNAF:OTCMKTS
Medicenna Therapeutics Corp
USD 0,31
0,00%
(0,00) 1D
7 Okt., 15:30:33 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDNAF...
Mkt. cap
41,21 m
Avg. vol.
46,14 k
Volume
67,00
52-wk high
USD 1,43
52-wk low
USD 0,23
Beta
1,97
Shares outstanding
92,30 m
No. of employees
15
Mkt. cap
41,21 m
Avg. vol.
46,14 k
Volume
67,00
52-wk high
USD 1,43
52-wk low
USD 0,23
Beta
1,97
Shares outstanding
92,30 m
No. of employees
15
News stories
From web sources and news partners
About Medicenna Therapeutics Corp
CEO-
Employees15
Founded2015
HeadquartersToronto, Ontario, Kanada
Sector-
Websitemedicenna.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,11 m
4,07 m
4,50 m
4,24 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,36 m
1,54 m
1,32 m
1,21 m
Operating expense
5,47 m
5,62 m
5,82 m
5,45 m
Total operating expenses
5,47 m
5,62 m
5,82 m
5,45 m
Operating income
-5,47 m
-5,62 m
-5,82 m
-5,45 m
Other non operating income
200,00 k
1,29 m
1,51 m
400,00 k
EBT including unusual items
-4,88 m
-4,36 m
-4,23 m
-5,08 m
EBT excluding unusual items
-4,88 m
-4,36 m
-4,23 m
-5,08 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,88 m
-4,36 m
-4,23 m
-5,08 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
158,00 k
114,00 k
53,00 k
25,00 k
Interest expense
-
-
-
-
Net interest expenses
158,00 k
114,00 k
53,00 k
25,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,46 m
-5,61 m
-5,82 m
-5,45 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme